A share price of Forte Biosciences Inc [FBRX] is currently trading at $12.76, down -12.96%%. In order to assess the stock’s recent performance, you can check whether its short-term value is rising or falling. The FBRX shares have gain 5.59% over the last week, with a monthly amount glided 79.47%, and seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
Previously, Ladenburg Thalmann upgraded its rating to Buy on April 08, 2024, and kept the price target unchanged to $2.75. On September 20, 2021, upgrade upgraded it’s rating to Buy and revised its price target to $3.50 on the stock. Truist downgraded its rating to a Hold but stick to its price target of $4 on September 03, 2021. Ladenburg Thalmann downgraded its rating to a Neutral. Chardan Capital Markets downgraded its rating to Sell for this stock on September 03, 2021, and downed its price target to $4. In a note dated September 03, 2021, B. Riley Securities downgraded an Neutral rating on this stock but restated the target price of $3.
Forte Biosciences Inc experienced fluctuations in its stock price throughout the past year between $4.11 and $28.68. Forte Biosciences Inc [NASDAQ: FBRX] shares were valued at $12.76 at the most recent close of the market.
Analyzing the FBRX fundamentals
To continue investigating profitability, this company’s Return on Assets is posted at -0.92, Equity is -1.49 and Total Capital is -1.17.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 9.96 points at the first support level, and at 7.17 for the second support level. However, for the 1st resistance point, the stock is sitting at 17.59, and for the 2nd resistance point, it is at 22.43.
Ratios To Look Out For
To put it in perspective, the Current Ratio for Forte Biosciences Inc [NASDAQ:FBRX] is 5.22. In addition, the Quick Ratio stands at 5.22 and the Cash Ratio stands at 5.08.
Transactions by insiders
Recent insider trading involved Riley Antony A, CHIEF FINANCIAL OFFICER, that happened on Nov 21 ’24 when 22514.0 shares were purchased.
